Clara David

518 total citations
12 papers, 245 citations indexed

About

Clara David is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Clara David has authored 12 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Clara David's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 detection and testing (4 papers). Clara David is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 detection and testing (4 papers). Clara David collaborates with scholars based in Belgium, France and United Kingdom. Clara David's co-authors include Jonathan Douxfils, Julien Favresse, Constant Gillot, Marc Elsen, Christine Eucher, Sandrine Van Eeckhoudt, Jean‐Michel Dogné, Jean‐Louis Bayart, Mélanie Closset and Laure Morimont and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Virology and Biomolecules.

In The Last Decade

Clara David

11 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara David Belgium 7 213 42 37 37 28 12 245
Leo L. H. Luk Hong Kong 5 257 1.2× 24 0.6× 53 1.4× 46 1.2× 41 1.5× 8 273
Sandrine Van Eeckhoudt Belgium 8 380 1.8× 36 0.9× 61 1.6× 57 1.5× 41 1.5× 11 405
Cas LeMaster United States 6 181 0.8× 28 0.7× 30 0.8× 33 0.9× 25 0.9× 11 202
David X. Lee United States 5 272 1.3× 49 1.2× 47 1.3× 35 0.9× 28 1.0× 7 287
Franziska Hielscher Germany 5 253 1.2× 37 0.9× 73 2.0× 64 1.7× 40 1.4× 8 301
Wai Hung Chan Hong Kong 7 328 1.5× 27 0.6× 35 0.9× 35 0.9× 33 1.2× 11 373
Nicole Perkmann‐Nagele Austria 9 261 1.2× 28 0.7× 21 0.6× 40 1.1× 13 0.5× 19 304
David Hillus Germany 4 282 1.3× 39 0.9× 45 1.2× 33 0.9× 47 1.7× 8 300
Christine Eucher Belgium 11 474 2.2× 38 0.9× 63 1.7× 62 1.7× 53 1.9× 14 494
Noëlla Pierlet Belgium 3 197 0.9× 32 0.8× 32 0.9× 42 1.1× 13 0.5× 5 225

Countries citing papers authored by Clara David

Since Specialization
Citations

This map shows the geographic impact of Clara David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara David more than expected).

Fields of papers citing papers by Clara David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara David. The network helps show where Clara David may publish in the future.

Co-authorship network of co-authors of Clara David

This figure shows the co-authorship network connecting the top 25 collaborators of Clara David. A scholar is included among the top collaborators of Clara David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara David. Clara David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
3.
Favresse, Julien, et al.. (2024). Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster. International Journal of Infectious Diseases. 143. 107028–107028. 7 indexed citations
4.
Favresse, Julien, Marie Tré‐Hardy, Constant Gillot, et al.. (2024). Vaccine‐induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?. Heliyon. 10(16). e36116–e36116. 1 indexed citations
5.
Favresse, Julien, Constant Gillot, Mélanie Closset, et al.. (2024). Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster. Journal of Medical Virology. 96(1). e29365–e29365. 5 indexed citations
6.
Morimont, Laure, Mélanie Dechamps, Clara David, et al.. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules. 12(8). 1038–1038. 24 indexed citations
7.
Favresse, Julien, Constant Gillot, Jean‐Louis Bayart, et al.. (2022). Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster. Journal of Medical Virology. 95(1). e28164–e28164. 21 indexed citations
8.
Favresse, Julien, Clara David, Constant Gillot, et al.. (2022). Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity. Viruses. 14(8). 1653–1653. 11 indexed citations
9.
Bayart, Jean‐Louis, Laure Morimont, Mélanie Closset, et al.. (2021). Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2. Microorganisms. 9(6). 1340–1340. 26 indexed citations
10.
David, Clara, et al.. (2021). New insights into the GDF9-Hedgehog-GLI signaling pathway in human ovaries: from fetus to postmenopause. Journal of Assisted Reproduction and Genetics. 38(6). 1387–1403. 4 indexed citations
11.
Bayart, Jean‐Louis, Jonathan Douxfils, Constant Gillot, et al.. (2021). Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers. Vaccines. 9(10). 1092–1092. 85 indexed citations
12.
Favresse, Julien, Constant Gillot, Christine Eucher, et al.. (2021). Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 13(7). 1364–1364. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026